Graves' disease is an autoimmune hyperthyroidism causing an overactive thyroid and associated symptoms.
✦ AI summary
Here's what this set of research sources says about Graves' Disease:
Graves' disease is an autoimmune condition where stimulating antibodies act on the thyroid's TSH receptor, and research shows these same antibodies also boost related receptors (like the IGF-1 receptor) on eye tissue fibroblasts, which may help explain why some people develop thyroid eye disease (TED) [8]. TED itself is a major focus of research: even "mild" TED, the most common form, is under-studied and can affect quality of life, with treatments like selenium having uncertain benefit in long-standing cases [5]. Some studies also look at outside factors affecting TED risk — cannabis use was linked to a higher short-term chance of certain eye symptoms compared to non-users [1], while a case report described a patient whose TED treatment (teprotumumab) led to high blood sugar linked to increased growth hormone activity [7]. On the medication side, one case report cautions that persistent low blood cell counts in someone on long-term methimazole (a common Graves' treatment) could reflect a separate serious blood disorder rather than just a known drug side effect [9]. Genetic research using population data suggests Graves' disease may actually lower the risk of prostate c
This is an AI-generated summary of the sources below — not medical advice. Always talk to a doctor or pharmacist about your own situation.
The purpose of this study is to investigate the association between cannabis usage and thyroid eye disease (TED) in patients with autoimmune hyperthyroidism. While the association between cigarette smoking and TED is well established, the effect of cannabis on TED is unclear. This cohort study exami…
Causal effect of thyroid function on cortical brain structure: A two-sample Mendelian randomization study.
The causal relationship between variations in thyroid dysfunction and brain structure remains elusive. We intended to probe into this causal connection using a Mendelian randomization (MR) approach. Aggregated statistics from the genome-wide Association Study (GWAS) on Autoimmune thyroid dysfunction…
Causal association and shared mechanisms between Graves' disease and prostate cancer: insights from Mendelian randomization, machine learning, and comprehensive bioinformatics.
Observational studies link hyperthyroidism to increased prostate cancer (PCa) risk, but causality and mechanisms remain unclear. Graves' disease (GD), the primary cause of hyperthyroidism, involves chronic immune dysregulation that may influence PCa through shared immune pathways. We performed bidir…
Brain network alterations in autoimmune diseases: Current status and future prospects.
Autoimmune diseases are frequently associated with neurological and cognitive dysfunction. Advances in neuroimaging and graph theory-based connectomics have enabled investigation of large-scale brain network alterations across autoimmune conditions. This review synthesizes structural and functional…
Stimulating Thyrotropin Receptor Antibodies Enhance the Expression of Both Thyrotropin Receptors and Insulin-Like Growth Factor 1 Receptors in Fibroblasts.
Thyrotropin (TSH) and insulin-like growth factor 1 (IGF-1) signals have been shown to be additive in their action on thyroid cells and fibroblasts, and this coordination emphasizes the role of TSH receptor (TSHR) and IGF-1 receptor (IGF-1R) signaling exerted by stimulating TSHR antibodies in patient…
Mild Thyroid Eye Disease-The Most Common yet the Least Studied Presentation of Thyroid Eye Disease.
Mild thyroid eye disease (TED) is the most common form of TED, yet it is the least studied. Uncertainties about the natural history and prevention, and underfunding for clinical research, are an obstacle to improving the management of this important group of patients. The available evidence suggests…
Thyroid eye disease with teprotumumab-related hyperglycemia associated with increased growth hormone secretion.
Teprotumumab, an insulin-like growth factor-1 (IGF-1) receptor antibody, has been approved for thyroid eye disease (TED) treatment. However, teprotumumab is associated with adverse events such as hyperglycemia, and the underlying mechanisms of teprotumumab-related hyperglycemia remain unclear. We re…
Clinical outcomes of thyroid function in patients with thyrotropin receptor blocking antibody-positive hypothyroidism.
Thyrotropin receptor blocking antibodies (TBAbs) are uncommon but not a rare cause of hypothyroidism. However, clinical outcomes of thyroid function in patients with TBAb-positive hypothyroidism remain unclear. The aim of this study was to explore the clinical outcomes of thyroid function in patient…